Yu Kang

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors

Predictions of Response in Non-small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors Using Clinical Data, Deep Learning, and Radiomics

Awareness and usage of a dietary guide by cancer patients and clinicians: a national survey study

Development and Clinical Trial of M701, an Anti-EpCAM × Anti-CD3 Bispecific Antibody: A Targeted Intraperitoneal Therapy for Malignant Ascites Stemming from Advanced Solid Tumors

All-2D-Materials Subthreshold-Free Field-Effect Transistor with Near-Ideal Switching Slope

SHANK2-AS3: A potential biomarker for Parkinson's disease and its role in neuronal apoptosis via NF-κB signaling in SH-SY5Y cells

Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells

Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens

Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer

Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma